These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9158079)

  • 1. Bone effects of transdermal hormone replacement therapy in postmenopausal women as evaluated by means of ultrasound: an open one-year prospective study.
    de Aloysio D; Rovati LC; Cadossi R; Paltrinieri F; Mauloni M; Mura M; Penacchioni P; Ventura V
    Maturitas; 1997 May; 27(1):61-8. PubMed ID: 9158079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring bone effect of transdermal hormone replacement therapy by ultrasound investigation at the phalanx: a four-year follow-up study.
    Mauloni M; Rovati LC; Cadossi R; de Terlizzi F; Ventura V; de Aloysio D
    Menopause; 2000; 7(6):402-12. PubMed ID: 11127763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative ultrasound at the hand phalanges in women on hormone replacement therapy.
    Pluskiewicz W; Drozdzowska B; Straszak L
    Ultrasound Med Biol; 2003 Dec; 29(12):1691-5. PubMed ID: 14698336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
    Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P
    J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporosis prevention clinical study program.
    Delmas P; Gimona A
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S39-45. PubMed ID: 8732473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of postmenopausal osteoporosis: how effective is transdermal hormone substitution? (Continuous estradiol plus sequential oral norethisterone acetate)].
    Gass R; Neff M
    Schweiz Med Wochenschr; 1995 Aug; 125(34):1583-91. PubMed ID: 7569830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound velocity changes at the proximal phalanxes of the hand in pre-, peri- and postmenopausal women.
    Ventura V; Mauloni M; Mura M; Paltrinieri F; de Aloysio D
    Osteoporos Int; 1996; 6(5):368-75. PubMed ID: 8931031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound transmission speed and ultrasound bone profile score (UBPS) of the phalanges in normal women and women with osteoporosis.
    Soballa T; Wüster C; Schlegel J; Cadossi R; Isani R; Battista S; Heilmann P; Ziegler R
    Horm Metab Res; 1998 Aug; 30(8):536-41. PubMed ID: 9761387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women.
    Laivuori H; Koistinen HA; Karonen SL; Cacciatore B; Ylikorkala O
    Hum Reprod; 2001 Aug; 16(8):1632-5. PubMed ID: 11473954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
    Chiantera V; Sarti CD; Fornaro F; Farzati A; De Franciscis P; Sepe E; Borrelli AL; Colacurci N
    Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ability of ultrasound bone profile score (UBPS) to discriminate between fractured and not fractured osteoporotic women.
    Di Stefano M; Isaia GC
    Ultrasound Med Biol; 2002; 28(11-12):1485-9. PubMed ID: 12498944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of transdermal oestrogen therapy in postmenopausal women: a comparative study of an oestradiol gel and an oestradiol delivering patch.
    Hirvonen E; Cacciatore B; Wahlström T; Rita H; Wilén-Rosenqvist G
    Br J Obstet Gynaecol; 1997 Nov; 104 Suppl 16():26-31. PubMed ID: 9389780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low and conventional dose transdermal oestradiol are equally effective at preventing bone loss in spine and femur at all post-menopausal ages.
    Evans SF; Davie MW
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):79-84. PubMed ID: 8706298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.
    Taskinen MR; Puolakka J; Pyörälä T; Luotola H; Bjäörn M; Kääriänen J; Lahdenperä S; Ehnholm C
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1215-21. PubMed ID: 8857916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal oestradiol gel in the treatment of the climacterium: a comparison with oral therapy.
    Hirvonen E; Lamberg-Allardt C; Lankinen KS; Geurts P; Wilén-Rosenqvist G
    Br J Obstet Gynaecol; 1997 Nov; 104 Suppl 16():19-25. PubMed ID: 9389779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal bone loss: does HRT always work?
    Stevenson JC; Hillard TC; Lees B; Whitcroft SI; Ellerington MC; Whitehead MI
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 2():88-91. PubMed ID: 8252111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasonographic measurement of endometrial thickness during hormonal replacement therapy in postmenopausal women.
    Affinito P; Palomba S; Pellicano M; Sorrentino C; Di Carlo C; Morgera R; Arienzo MP; Nappi C
    Ultrasound Obstet Gynecol; 1998 May; 11(5):343-6. PubMed ID: 9644774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 10 years' hormone replacement therapy on bone mineral content in postmenopausal women.
    Eiken P; Kolthoff N; Nielsen SP
    Bone; 1996 Nov; 19(5 Suppl):191S-193S. PubMed ID: 8922661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential addition of low dose of medrogestone or medroxyprogesterone acetate to transdermal estradiol: a pilot study on their influence on the endometrium.
    Pansini F; De Paoli D; Albertazzi P; Bonaccorsi G; Campobasso C; Zanotti L; Pisati R; Giulini NA
    Eur J Obstet Gynecol Reprod Biol; 1996 Sep; 68(1-2):137-41. PubMed ID: 8886696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.